Joshua Kazam is a co-founder and Partner of Two River, where he has served as partner since its inception in 2004. He is a co-founder and partner of Vida Ventures, LLC, a life science investment firm and is a co-founder and Director of Breakthrough Properties, LLC, and an advisor to Symbiotic Capital. Joshua is a co-founder and director of Allogene Therapeutics. Inc. (ALLO), and was a co-founder and director of Kite Pharma, Inc., where he served on the Board of Directors from inception until its acquisition by Gilead Sciences, Inc. in 2017. Joshua also serves as a director of several privately held companies including ByHeart Inc, and Hubble Contacts, Inc. Joshua is a Penn Medicine Trustee, and a member of the Wharton School’s Undergraduate Executive Board. He also currently serves on the Board of the Desert Flower Foundation and of Citymeals on Wheels New York. He received his B.S. in Economics from the Wharton School of the University of Pennsylvania.